- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06368323
Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia
The goal of this randomized controled trial is to test the effects of assigning people with chronic post-stroke aphasia to 12 weekly choir sessions, compared to usual care.
The main question it aims to answer is:
Does the assignment to a choir singing program causes a beneficial effect on functional communication and language recovery as well as psychosocial outcomes compared to usual care in the rehabilitation of people with chronic post-stroke aphasia?
Participants will have:
12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master, and home singing training (3 x 30-minutes-sessions/week, total 18h)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Description of study population Additional information: Participants with chronic aphasia due to stroke will be recruited from four participating centers in Canada and the United States.
Study design Additional information: A parallel group randomized trial design with a secondary crossover extension was chosen for this study to offer the intervention to all participants. Participants will be randomized in a 1:1 ratio to two study arms (AB/BA, A = 12 weekly choir sessions and home singing training, B = usual care) stratified for aphasia severity (according to the Quick Aphasia Battery overall score), age, time since last stroke and their interest in music (according to the Barcelona Music Reward Questionnaire). Measures at the "macro" level will be collected at Baseline, Completion and 2-months Follow-up time points for each group. At the "micro" level (i.e., at choir sessions 2, 6, 10 and 12) data will be collected during as well as pre and post choir-singing.
Intervention Additional information: The repertoire in the comunity choir activity will consist of popular songs in English or French. Half of the songs will be pre-determined and half will be chosen by the choir members from a list, based on a vote during the first week of the intervention. Eligible songs will remain within the range of an octave and include a variety of tempi (but fast tempi will be slowed down if needed to facilitate word production). Depending on the group's abilities, the Choir Director will decide in which keys the songs will be performed, and whether they will be sung in unison or with simple harmonies. Songs in canon will be included in the predetermined repertoire to easily create harmonies. Each session will include (in this order): 15 minutes for vocal warm-up; 25 minutes of work on the song repertoire; 20 minutes for a social break with refreshments.
For the home training, participants will be instructed to sing at home with a video guide on an online platform. Each home training session will include (in this order): 10 minutes for vocal warm-up; and 20 minutes sing-along using songs of the repertoire. Song lyrics will be displayed on the video.
To monitor the usual care, each participant (and/or caregiver) will complete a form and/or have a weekly 5-15-minute phone/Zoom call with a research assistant to collect the usual care data including type and time spent in social activities and rehabilitation services, as well as adverse events.
Randomization and concealment For randomization, an online system will be used by a researcher not involved in data collection.
Each participant will be assigned an identification number upon inclusion in the study. After completion of the baseline assessments, the independent researcher will receive the list of participants' IDs with their stratification data (age, time post-stoke, aphasia severity, level of interest in music) to perform the randomization.
Blinding:
Outcomes will be measured by blinded assessors where possible, based on video or audio recordings.
Planned analyses:
Primary hypothesis:
Participants assigned to the choir intervention over 12 weeks will demonstrate a significantly larger improvement in macro-level measures compared to those receiving usual care.
Secondary hypothesis:
Participants who completed the choir intervention with 80% adherence over 12 weeks will demonstrate a larger improvement in macro-level measures compared to those receiving usual care.
The gains will be maintained for the participants with 80% adherence.
There will be immediate changes in micro-level measures after a choir session (Session 6).
There will be differences in pre-post-session variations of micro-level measures between Session 2, 6 and 10.
There will be differences in pre-post-session variations between the usual rehearsal (Session 10) and the Concert (Session 12).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna Zumbansen, PhD
- Phone Number: 8393 613-562-5800
- Email: azumbans@uottawa.ca
Study Contact Backup
- Name: Narges Bayat, Master
- Phone Number: 8393 613-562-5800
- Email: nbaya063@uottawa.ca
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N 6N5
- Completed
- University of Ottawa
-
Toronto, Ontario, Canada, M5B 0C3
- Recruiting
- Toronto Metropolitan University
-
Contact:
- Arla Good, Ph.D.
- Email: arla.good@torontomu.ca
-
-
Quebec
-
Montreal, Quebec, Canada, H3C 3J7
- Completed
- Université de Montréal
-
-
-
-
Florida
-
Tampa, Florida, United States, 33620
- Not yet recruiting
- University of South Florida
-
Contact:
- Jennifer Bugos, Ph.D.
- Email: bugosj@usf.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- People with chronic aphasia following stroke
- English or French as language of daily use
- Last stroke must have occurred at least 6 months before the start of the first assessments in the study protocol.
Exclusion Criteria:
- Regular music making in the past 6 months
- Visual deficit that cannot be corrected and might impair testing
- Hearing deficit that cannot be corrected and might impair testing
- Presence of neurological/psychiatric co-morbidity or substance abuse
- No ability to produce vocal sound through singing/humming
- Legally considered unable to make decisions for oneself
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AB Group
First choir, then usual care
|
The 12-week intervention will consist of 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master in addition to home training (3 x 30-minutes-sessions/week, total 18h).
In total, participants will undergo the intervention for 3 hours/week for 12 weeks (i.e., 36 hours).
Rehabilitation services received by patients and social activities will be monitored and documented.
|
|
Experimental: BA Group
First usual care, then choir
|
The 12-week intervention will consist of 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master in addition to home training (3 x 30-minutes-sessions/week, total 18h).
In total, participants will undergo the intervention for 3 hours/week for 12 weeks (i.e., 36 hours).
Rehabilitation services received by patients and social activities will be monitored and documented.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Communication Index
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
The ability to communicate one's feelings and basic needs effectively / is computed by averaging the percentage scores (score/total×100) of the Communicative Activity Log (CAL) and the communication subscale of the Stroke Impact Scale 3.0 (SIS). Minimum value=0; Maximum value=100; Higher scores mean a better outcome. |
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of confidence in communication
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Individual's subjective perception of their ability to effectively communicate in various situations / assessed with the Communication Confidence Rating Scale for Aphasia (CCRSA), a self-reported assessment in 10 questions. Minimum value=4; Maximum value=40; Higher scores mean a better outcome. |
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Aphasia severity index
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
The aphasia severity index quantifies the extent of language impairment experienced by individuals with aphasia / assessed using the Quick Aphasia Battery (QAB). Minimum value=0; Maximum value=10; Higher scores mean a better outcome. |
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Speech and language in functional communication
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
The ability of an individual to effectively use verbal communication skills / assessed with a part of the AphasiaBank protocol to elicit connected speech in participants Minimum value=0; Maximum value=100; Higher scores mean a better outcome.
|
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Apraxia of speech severity
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
The degree or level of impairment in the motor planning and execution of speech movements / assessed with the Apraxia of Speech Rating Scale (ASRS-3.5)
experienced by individuals with apraxia Minimum value=0; Maximum value=52; Higher scores mean a worse outcome.
|
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Emotional wellbeing
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
The state of an individual's mental and emotional health, encompassing their overall mood, psychological resilience, and ability to cope with stressors and life challenges / assessed using the General Health Questionnaire (GHQ-12) Minimum value=0; Maximum value=36; Higher scores mean a worse outcome.
|
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Social participation
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Active engagement of individuals within their community or society, involving various social activities, interactions, and roles. / assessed using the corresponding SIS participation subscale. Minimum value=8; Maximum value=40; Higher scores mean a better outcome. |
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Generic measure of health
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Short-Form 6-Dimension version 2 (SF-6Dv2) is a survey on 6 health domains: Physical functioning, Role functioning, Pain, Vitality, Social functioning, Mental health. Minimum value= 0; Maximum value= 100;Higher scores mean a better outcome. |
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Appetence to music
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
An individual's inclination or attraction towards music / Barcelona Music Reward Questionnaire (BMRQ) Minimum value= 20; Maximum value= 100 ; Higher scores mean a better outcome. |
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Health related quality of life assessed by the the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39)
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Individual's subjective perception of their physical, emotional, mental, and social well-being in relation to their health status and the impact of illness or treatment on their overall quality of life / assessed with the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39) Minimum value=39; Maximum value=195; Higher scores mean a better outcome.
|
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
|
Singing voice abilities
Time Frame: T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Overall singing voice quality, tuning and rhythmic accuracy / assessed following a standardized protocol
|
T1 (baseline, week 1), T2 (week 15), T3 (week 16), T4 (week 30), T5 (week 31)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Voice - Pitch
Time Frame: Before and afrer choir sessions 2, 6, 10 and 12
|
Pitch mean, standard deviation, and range in spontaneous speech based on a quick standardized voice production protocol
|
Before and afrer choir sessions 2, 6, 10 and 12
|
|
Voice - Maximum Phonation Time
Time Frame: Before and afrer choir sessions 2, 6, 10 and 12
|
Maximum Phonation Time based on a quick standardized voice production protocol
|
Before and afrer choir sessions 2, 6, 10 and 12
|
|
Voice - Dynamic range
Time Frame: Before and afrer choir sessions 2, 6, 10 and 12
|
Dynamic range based on a quick standardized voice production protocol
|
Before and afrer choir sessions 2, 6, 10 and 12
|
|
Biosocial indexes
Time Frame: Before and afrer choir sessions 2, 6, 10 and 12
|
Cortisol and oxytocin measures / measured in salivary samples
|
Before and afrer choir sessions 2, 6, 10 and 12
|
|
Mood
Time Frame: The first and last 10 minutes of sessions 2, 6, 10 and 12 as well as the last 10 minutes of the break.
|
Temporary state of mind or temper / assessed with the Observed Emotion Rating Scale (OERS), an observational tool for rating two positive emotions (pleasure and general alertness) and three negative emotions (anger, anxiety or fear, and sadness) over a defined 10-minute period.
A longer display of emotion is indicated by higher scores.
|
The first and last 10 minutes of sessions 2, 6, 10 and 12 as well as the last 10 minutes of the break.
|
|
Expectations on a 100-scale
Time Frame: T1 (baseline, week 1),T5 (week 31)
|
Measures expectations based on a feedback questionnaire.
Minimum value=0; Maximum value=100; Higher scores mean a better outcome.
|
T1 (baseline, week 1),T5 (week 31)
|
|
Satisfaction on a 100-scale
Time Frame: T1 (baseline, week 1),T5 (week 31)
|
Measures satisfaction based on a feedback questionnaire.
Minimum value=0; Maximum value=100; Higher scores mean a better outcome.
|
T1 (baseline, week 1),T5 (week 31)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Frank Russo, PhD, Toronto Metropolitan University
- Principal Investigator: Anna Zumbansen, PhD, University of Ottawa
- Principal Investigator: Arla Good, PhD, Toronto Metropolitan University
- Principal Investigator: Carole Anglade, PhD, Université de Montréal
- Principal Investigator: Édith Durand, PhD, Université du Québec à Trois-Rivières
- Principal Investigator: Jennifer Bugos, PhD, University of South Florida
Publications and helpful links
General Publications
- Siponkoski ST, Pitkaniemi A, Laitinen S, Sarkamo ER, Pentikainen E, Eloranta H, Tuomiranta L, Melkas S, Schlaug G, Sihvonen AJ, Sarkamo T. Efficacy of a multicomponent singing intervention on communication and psychosocial functioning in chronic aphasia: a randomized controlled crossover trial. Brain Commun. 2022 Dec 27;5(1):fcac337. doi: 10.1093/braincomms/fcac337. eCollection 2023.
- Anna Zumbansen, Isabelle Peretz, Carole Anglade, Josée Bilodeau, Suzanne Généreux, Michelyne Hubert & Sylvie Hébert (2017) Effect of choir activity in the rehabilitation of aphasia: a blind, randomised, controlled pilot study, Aphasiology, 31:8, 879-900, DOI: 10.1080/02687038.2016.1227424
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-01-24-9931
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aphasia
-
Teachers College, Columbia UniversityRecruitingAphasia | Aphasia, Acquired | Aphasia, Broca | Aphasia Non Fluent | Aphasia, Anomic | Aphasia Following Cerebral Infarction | Aphasia, Mixed | Aphasia, Expressive | Aphasia, Conduction | Aphasia, RehabilitationUnited States
-
University of South CarolinaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Aphasia | Stroke, Ischemic | Aphasia, Broca | Aphasia, Anomic | Aphasia, Global | Aphasia, Fluent | Aphasia, Mixed | Aphasia, Jargon | Aphasia, Expressive | Aphasia, ConductionUnited States
-
Maya HenryNational Institutes of Health (NIH); National Institute on Aging (NIA)RecruitingSemantic Dementia | Logopenic Progressive Aphasia | Nonfluent Aphasia, Progressive | Logopenic Variant Primary Progressive Aphasia | Semantic Variant Primary Progressive Aphasia (svPPA) | Nonfluent Variant Primary Progressive Aphasia (nfvPPA) | Progressive Aphasia | Logopenic Progressive Aphasia... and other conditionsUnited States
-
University of California, BerkeleyUniversity of California, San Francisco; National Institute on Deafness and... and other collaboratorsRecruitingAphasia | Aphasia, Acquired | Aphasia Following Cerebral Infarction | Aphasia, Non-fluent | Aphasia, Fluent | Aphasia Following Nontraumatic Intracerebral HemorrhageUnited States
-
Maya HenryNational Institute on Aging (NIA)RecruitingLogopenic Variant Primary Progressive Aphasia | Progressive Aphasia | Logopenic Progressive Aphasia (LPA) | Primary Progressive Aphasia(PPA) | Logopenic Variant of Primary Progressive Aphasia (LPA) | Progressive Aphasia in Alzheimer's DiseaseUnited States
-
University of Texas at AustinUniversity of California, San Francisco; National Institute on Deafness and...Active, not recruitingPrimary Progressive Aphasia | Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Semantic Memory Disorder | Nonfluent Aphasia, Progressive | Aphasia, ProgressiveUnited States
-
University of Texas at AustinNational Institute on Deafness and Other Communication Disorders (NIDCD)Enrolling by invitationPrimary Progressive Aphasia | Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Semantic Memory Disorder | Nonfluent Aphasia, Progressive | Aphasia, ProgressiveUnited States
-
Institute for Bioengineering of CataloniaHospital Universitari Joan XXIII de Tarragona.; Universitat Pompeu FabraCompletedAphasia | Aphasia, Broca | Aphasia, Wernicke | Aphasia, Fluent | Aphasia, NonfluentSpain
-
Flint Rehabilitation Devices, LLCUniversity of TexasCompleted
-
Mayo ClinicNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingPrimary Progressive Aphasia | Apraxia of Speech | PPA | Non-fluent Aphasia | Primary Progressive Non-fluent AphasiaUnited States
Clinical Trials on Choir singing
-
Toronto Metropolitan UniversityMitacs; Sonova AGTerminatedAging | Hearing Loss | Music Therapy | Auditory PerceptionCanada
-
University of Southern CaliforniaRecruitingAnxiety | Social Behavior | Speech PerceptionUnited States
-
NORCE Norwegian Research Centre ASUniversity of Nottingham; University Medical Center Groningen; University of... and other collaboratorsCompletedDepression | DementiaUnited Kingdom, Australia, Germany, Netherlands, Norway, Turkey
-
Stockholm UniversityThe Swedish Research Council; Region StockholmCompletedIrritable Bowel SyndromeSweden
-
Norwegian Academy of MusicUniversity of Oslo; Oslo Municipality; Institute of Clinical Medicine, University...Active, not recruitingDementia | Informal Caregivers (Family and Friends)Norway
-
Iolanda Costa GalinhaDGArtes - Direção Geral das Artes; CIS-Iscte - Centro de Investigação e Intervenção...CompletedDepression | Quality of Life | Body Weight | Stress | Sleep | Anxiety | Blood Pressure | Cognitive Function | Blood Glucose | Loneliness | Physical Function | Medication Compliance | Balance | Memory | Biomarker | Well-Being | Respiratory Function | Social Identification | Cholesterol | C-reactive Protein | Erythrocyte Sedimentation Rate and other conditionsPortugal
-
Royal Marsden NHS Foundation TrustLondon Cancer Alliance; Royal College of Music; Tenovus Cancer CareUnknownCancerUnited Kingdom
-
University of Southern CaliforniaCompleted
-
University of HelsinkiKarolinska University Hospital; Helsinki University Central HospitalCompletedNeurocognitive Dysfunction | Language Development
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedChronic Obstructive Pulmonary DiseaseBrazil